Interestingly, when we confined the data of gastric cancer patients with stage 2 to 4 disease, patients with lymph node metastasis, and patients treated with surgery alone, a correlation between decreased TXNIP and good survival outcomes was observed (Additional file 8: Table S2). The gene discussed is TXNIP; the disease is metastatic malignant neoplasm in the lymph nodes.